Versantis
Michael Sidler is a board member at Versantis. Michael has also been a part of companies such as Sanity Group, Araris Biotech AG, Mushlabs, ImmunOs Therapeutics AG, aktiia, SECA - Swiss Private Equity & Corporate Finance Association, and Memo Therapeutics AG. Sidler has also been a part of Redalpine Venture Partners.
Michael Sidler has a background in Executive Programs from Singularity University and a PhD in Plant Molecular Biology from the University of Zurich.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Versantis
Versantis is a pharmaceutical company developing a new generation of orphan medicine to revolutionize the care of patients.